Ysbyty Gwynedd is a district general hospital in Bangor, Gwynedd, Wales. It is managed by Betsi Cadwaladr University Health Board.

There are 463 beds in Ysbyty Gwynedd.

During the past decade, Ysbyty Gwynedd conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ysbyty Gwynedd" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 5 trials, followed by "Lymphoma Trials Office" with 3 trials sponsored, "Medical Research Council" with 3 trials sponsored, "University College, London" with 3 trials sponsored and "Lisette Nixon" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ysbyty Gwynedd" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Ysbyty Gwynedd" are "Lymphoma" (8 trials), "Breast Cancer" (6 trials), "Fallopian Tube Cancer" (5 trials), "Ovarian Cancer" (5 trials) and "Primary Peritoneal Cavity Cancer" (4 trials). Many other conditions were trialed in "Ysbyty Gwynedd" in a lesser frequency.

Most popular intervention types in "Ysbyty Gwynedd" are "Drug" (40 trials), "Procedure" (16 trials), "Biological" (8 trials), "Other" (6 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (8 trials), "quality-of-life assessment" (6 trials), "adjuvant therapy" (5 trials), "carboplatin" (4 trials) and "doxorubicin hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ysbyty Gwynedd" are 34 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ysbyty Gwynedd". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Ysbyty Gwynedd, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ysbyty Gwynedd, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".